Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Neuromuscular Disorders : NMD|July 8, 2008
In vivo delivery of naked antisense oligos in aged mdx mice: analysis of dystrophin restoration in skeletal and cardiac muscleLibero Vitiello, Nicola Bassi, Paola Campagnolo, et al.Journal of Neuro-Oncology|January 4, 2015
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care centerFilippo Ceccato, Giuseppe Lombardi, Renzo Manara, et al.Endocrine-Related Cancer|March 21, 2025
Exploring the tumor suppressor role of RIN1 in familial thyroid carcinomaLuna Picello, Mattia Dalle Nogare, Daniele Puggina, et al.Endocrine-Related Cancer|March 17, 2022
The GIP/GIPR axis in medullary thyroid cancer: clinical and molecular findingsDaniela Regazzo, Loris Bertazza, Eva Galletta, et al.Plos Genetics|April 5, 2013
A novel mutation in the upstream open reading frame of the CDKN1B gene causes a MEN4 phenotypeGianluca Occhi, Daniela Regazzo, Giampaolo Trivellin, et al.The Journal of Clinical Endocrinology and Metabolism|October 5, 2018
Paradoxical GH Increase During OGTT Is Associated With First-Generation Somatostatin Analog Responsiveness in AcromegalyCarla Scaroni, Nora Albiger, Andrea Daniele, et al.Plos One|July 15, 2014
AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-upCaterina Mian, Filippo Ceccato, Susi Barollo, et al.BMC Medical Genetics|October 30, 2007
Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitroGiorgia Beffagna, Marzia De Bortoli, Andrea Nava, et al.Endocrinology|June 14, 2014
Activation of the dopamine receptor type-2 (DRD2) promoter by 9-cis retinoic acid in a cellular model of Cushing's disease mediates the inhibition of cell proliferation and ACTH secretion without a complete corticotroph-to-melanotroph transdifferentiationGianluca Occhi, Daniela Regazzo, Nora Maria Albiger, et al.Oncotarget|September 23, 2015
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTCGianluca Occhi, Susi Barollo, Daniela Regazzo, et al.Pageof 4